Razaxaban

DB19834ExperimentalSmall molecule

Razaxaban is a small molecule drug. The usage of the INN stem '-xaban' in the name indicates that Razaxaban is a blood coagulation factor XA inhibitor, antithrombotic. Razaxaban has a... Razaxaban has a monoisotopic molecular weight of 528.16 Da.

Formula / weight: C₂₄H₂₀F₄N₈O₂ · 528.472 g/mol (avg)

Resolves to

Compound

UNII3K2509846LCAS218298-21-6ChEMBLCHEMBL206335ChEBI748737PubChem204102

Structure

InChIKeyOFJRNBWSFXEHSA-UHFFFAOYSA-NSMILESCN(C)CC1=NC=CN1C1=CC(F)=C(NC(=O)C2=CC(=NN2C2=CC=C3ON=C(N)C3=C2)C(F)(F)F)C=C1

Targets

P00742F10P12259F5 P00734F2 P00740F9

What you can answer from here — as of September 23, 2026

4Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

10+ReferencesStructured and connected to the statements they support

Which drugs share a target with Razaxaban, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account